530084-81-2 Usage
Description
[1,1-Biphenyl]-3-amine,6-ethoxy-(9CI) is a chemical compound characterized by the molecular formula C14H15NO. It is a substituted biphenyl amine with an ethoxy group attached to the sixth carbon. This unique structure and properties make it a compound of interest in the pharmaceutical and chemical industries.
Uses
Used in Pharmaceutical Industry:
[1,1-Biphenyl]-3-amine,6-ethoxy-(9CI) is used as a building block for the synthesis of organic compounds, which can be further utilized in the development of new drugs. Its specific chemical structure makes it a promising candidate for medicinal chemistry and drug discovery research.
Used in Chemical Industry:
In the chemical industry, [1,1-Biphenyl]-3-amine,6-ethoxy-(9CI) may serve as a precursor for the creation of various organic compounds, contributing to the advancement of chemical synthesis and the development of novel materials.
Further study and experimentation with [1,1-Biphenyl]-3-amine,6-ethoxy-(9CI) may reveal additional potential applications in both the pharmaceutical and chemical industries, as well as other scientific fields.
Check Digit Verification of cas no
The CAS Registry Mumber 530084-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,0,0,8 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 530084-81:
(8*5)+(7*3)+(6*0)+(5*0)+(4*8)+(3*4)+(2*8)+(1*1)=122
122 % 10 = 2
So 530084-81-2 is a valid CAS Registry Number.
530084-81-2Relevant articles and documents
Aryl aniline beta2 adrenergic receptor agonists
-
Page 41, (2008/06/13)
The invention provides novel β2 adrenergic receptor agonist compounds of formula (I): wherein R1-R13 and w have any of the values described in the specification. The invention also provides combinations of such compounds and other therapeutic agents, pharmaceutical compositions comprising such compounds and combinations, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
